Comparison of the efficacy and safety of paclitaxel-eluting coroflex please stents and paclitaxel-eluting stents in patients with coronary artery disease: A randomized PIPA trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hyun-Sook | - |
dc.contributor.author | Park, Seung-Jung | - |
dc.contributor.author | Park, Duk-Woo | - |
dc.contributor.author | Park, Seong-Wook | - |
dc.contributor.author | Cheong, Sang-Sig | - |
dc.contributor.author | Lee, Sang-Gon | - |
dc.contributor.author | Cho, Byung-Ryul | - |
dc.contributor.author | Lee, Seung-Wook | - |
dc.contributor.author | Lee, Nae-Hee | - |
dc.contributor.author | Lee, Keun | - |
dc.date.accessioned | 2021-08-12T02:26:49Z | - |
dc.date.available | 2021-08-12T02:26:49Z | - |
dc.date.issued | 2012-11-01 | - |
dc.identifier.issn | 1522-1946 | - |
dc.identifier.issn | 1522-726X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/14697 | - |
dc.description.abstract | Objectives: To compare the safety and efficacy of the new Coroflex (TM) Please stents with conventional Taxus (TM) Liberte stents in patients with coronary artery lesions. Background: The Coroflex (TM) Please stent is a new version of paclitaxel-eluting stent, and observational cohort studies have reported similar angiographic and clinical outcomes as with the first-generation stents. However, it has not been directly compared with the early generation paclitaxel-eluting stents in a multicenter, prospective, and randomized study. Methods: We randomly assigned 319 patients to receive Coroflex (TM) Please stents (159 patients; 198 lesions) or Taxus (TM) Liberte stents (160 patients; 232 lesions). The primary end point was angiographic in-segment late luminal loss at 9 months. Results: Most baseline clinical and angiographic characteristics were similar between these two groups. The Coroflex (TM) Please and Taxus (TM) Liberte stents showed similar in-segment late loss (0.40 +/- 0.53 mm vs. 0.39 +/- 0.52 mm, P = 0.98) and rates of in-segment binary restenosis (22.2% vs. 18.8%, P = 0.48) at 9 months. After clinical follow-up for 12 months, the two groups had similar rates of death (1.3% vs. 1.3%, P > 0.99), myocardial infarction (3.8% vs. 7.5%, P = 0.22), stent thrombosis (2.5% vs. 1.9%, P = 0.72), and target-lesion revascularization (7.5% vs. 7.5%, P = 0.99). Conclusions: The Coroflex (TM) Please stent resulted in similar angiographic and clinical outcomes as the Taxus (TM) Liberte stent in patients with coronary artery lesions. (c) 2012 Wiley Periodicals, Inc. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | John Wiley & Sons Inc. | - |
dc.title | Comparison of the efficacy and safety of paclitaxel-eluting coroflex please stents and paclitaxel-eluting stents in patients with coronary artery disease: A randomized PIPA trial | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1002/ccd.23440 | - |
dc.identifier.wosid | 000310472300017 | - |
dc.identifier.bibliographicCitation | Catheterization and Cardiovascular Interventions, v.80, no.5, pp 799 - 806 | - |
dc.citation.title | Catheterization and Cardiovascular Interventions | - |
dc.citation.volume | 80 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 799 | - |
dc.citation.endPage | 806 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | ANGIOGRAPHIC FOLLOW-UP | - |
dc.subject.keywordPlus | METAANALYSIS | - |
dc.subject.keywordPlus | RESTENOSIS | - |
dc.subject.keywordAuthor | paclitaxel | - |
dc.subject.keywordAuthor | drug-eluting stent | - |
dc.subject.keywordAuthor | Coroflex (TM) | - |
dc.subject.keywordAuthor | Please stent | - |
dc.subject.keywordAuthor | coronary artery disease | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.